Caladrius Biosciences Novice Eulerpool

Caladrius Biosciences Eulerpool News

Caladrius Biosciences Novice o delnici

Caladrius Biosciences spremljajo številni novinarji in vlagatelji po vsem svetu. Najnovejše Caladrius Biosciences novice zbiramo in objavljamo tukaj.

• 14. september ·

  Thefly.com
  Caladrius announces approval of merger, name change to Lisata Therapeutics
• 12. september ·

  Yahoo
  Life Sciences Virtual Investor Conference Agenda Announced for September 15th
• 8. september ·

  Yahoo
  Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022
• 2. september ·

  InvestorPlace
  Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
• 10. avgust ·

  Yahoo
  Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic Cancer
• 10. avgust ·

  TipRanks
  Analysts Conflicted on These Healthcare Names: Haemonetics (HAE), Caladrius Biosciences (CLBS) and Adicet Bio (ACET)
• 10. avgust ·

  Thefly.com
  Caladrius announces Cend's agreement with F. Hoffmann-La Roche
• 7. avgust ·

  TipRanks
  Dawson James Sticks to Its Hold Rating for Caladrius Biosciences (CLBS)
• 5. avgust ·

  TipRanks
  H.C. Wainwright Thinks Caladrius Biosciences’ Stock is Going to Recover
• 5. avgust ·

  SeekingAlpha
  Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q2 2022 Results - Earnings Call Transcript